Implementation of Glecaprevir-Pibrentasvir for Children Aged 3-12 Years With Chronic Hepatitis C: Multicentre Israeli Experience
Paediatrics
Implementation of Glecaprevir-Pibrentasvir for Children Aged 3-12 Years With Chronic Hepatitis C: Multicentre Israeli Experience
Paediatrics

Implementation of Glecaprevir-Pibrentasvir for Children Aged 3-12 Years With Chronic Hepatitis C: Multicentre Israeli Experience

Acta Paediatr. 2025 Feb 27. doi: 10.1111/apa.70045. Online ahead of print.

NO ABSTRACT

PMID:40013434 | DOI:10.1111/apa.70045